Other studies have reported lower plasma ACE-2 levels in non-survivors than in critically ill patients that have survived COVID-19 [30], however, our study has failed to demonstrate a difference in this parameter between those with critical illness and non-critical illness. Here, ACE2 is linked to COVID-19.